IL6 and colorectal carcinoma: Inflammatory bowel disease, particularly ulcerative colitis, is associated with an increased risk of developing CRC, characterized by inflammatory cell infiltration and elevated levels of inflammatory cytokines (e.g., IL-1β, IL-6, and TNFα) and chemokines (e.g., CCL2, and CXCL1) [58,59].